China Regulatory 2021 Deep-dive: Major Updates, IVD Regulatory Landscape, evolving Digital Health Frameworks
On September 14, 2021, Cisema, NAMSA and China Med Device will cohost a webinar session during the RAPS Convergence 2021, a four-day online event, to talk about the China regulatory with a deep-dive into the must-know trends, major changes and key product focus areas in 2021.
Learning Objectives of the session:
Latest trends and major NMPA regulatory updates
Latest overarching Order #739 and its implications on overseas medical device manufacturers.
China regulatory landscape for IVDs
Case studies will also be available.
Evolving digital health framework in China
There will also be a particular focus on AI/ML products as regulations respond to an exploding global growth in software products and capabilities.
The webinar session is a must watch for all China regulatory professionals covering medtech products in or entering the Chinese market.
Contact Cisema if you would like to learn more.
